BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33278670)

  • 21. Risk of second primary malignancies and causes of death in patients with adenocarcinoma and carcinoid of the small intestine.
    Zar N; Garmo H; Holmberg L; Hellman P
    Eur J Cancer; 2008 Mar; 44(5):718-25. PubMed ID: 18207733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased risk of colon cancer after external radiation therapy for prostate cancer.
    Rapiti E; Fioretta G; Verkooijen HM; Zanetti R; Schmidlin F; Shubert H; Merglen A; Miralbell R; Bouchardy C
    Int J Cancer; 2008 Sep; 123(5):1141-5. PubMed ID: 18546265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of a new primary cancer among patients with lung cancer of different histological types.
    Teppo L; Salminen E; Pukkala E
    Eur J Cancer; 2001 Mar; 37(5):613-9. PubMed ID: 11290437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Second primary cancers in breast cancer patients in Slovenia.
    Volk N; Pompe-Kirn V
    Cancer Causes Control; 1997 Sep; 8(5):764-70. PubMed ID: 9328199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased risk of chronic lymphocytic leukaemia among cancer survivors in the Netherlands: increased detection, causal factors or both?
    van den Broek EC; Liu L; Posthuma EF; Janssen-Heijnen ML; Coebergh JW; Soerjomataram I
    Ann Hematol; 2014 Jan; 93(1):157-62. PubMed ID: 24381068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second primary malignancies in patients with non-melanoma skin cancer: Results from a cancer registry-based study in Emilia Romagna, north-east Italy.
    Borghi A; Corazza M; Chiaranda G; Michiara M; Mangone L; Caruso B; Falcini F; Maestri I; Ferretti S
    Cancer Epidemiol; 2019 Aug; 61():176-184. PubMed ID: 31301588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.
    Herr MM; Schonfeld SJ; Dores GM; Engels EA; Tucker MA; Curtis RE; Morton LM
    Blood Adv; 2019 Jul; 3(13):1961-1969. PubMed ID: 31262739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.
    Herr MM; Schonfeld SJ; Dores GM; Withrow DR; Tucker MA; Curtis RE; Morton LM
    J Natl Cancer Inst; 2018 Nov; 110(11):1248-1258. PubMed ID: 29659938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of second primary malignancies in patients with chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2019.
    van der Straten L; Levin MD; Dinnessen MAW; Visser O; Posthuma EFM; Doorduijn JK; Langerak AW; Kater AP; Dinmohamed AG
    Blood Cancer J; 2023 Jan; 13(1):15. PubMed ID: 36635262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of multiple primary cancers following respiratory tract cancer in Umbria, Italy.
    Petrucci MS; Brunori V; Masanotti GM; Bianconi F; La Rosa F; Stracci F
    Ig Sanita Pubbl; 2013; 69(6):629-38. PubMed ID: 24548904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of Second Primary Malignancies in Patients with Neuroendocrine Tumours.
    Clift AK; Drymousis P; Al-Nahhas A; Wasan H; Martin J; Holm S; Frilling A
    Neuroendocrinology; 2015; 102(1-2):26-32. PubMed ID: 25824138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The risk of metachronous cancers in patients with small-intestinal carcinoid tumors: a US population-based study.
    Amin S; Warner RR; Itzkowitz SH; Kim MK
    Endocr Relat Cancer; 2012 Jun; 19(3):381-7. PubMed ID: 22454400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased risk of second primary malignancies in patients with gynecological cancer. A Swedish record-linkage study.
    Bergfeldt K; Einhorn S; Rosendahl I; Hall P
    Acta Oncol; 1995; 34(6):771-7. PubMed ID: 7576744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study.
    Giri S; Bhatt VR; Verma V; Pathak R; Bociek RG; Vose JM; Armitage JO
    Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):569-574. PubMed ID: 28709798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Secondary malignant neoplasms in patients with breast cancer].
    Dörffel WV; Reitzig P; Dörffel Y; Possinger K
    Zentralbl Gynakol; 2000; 122(8):419-27. PubMed ID: 11005133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second Primary Malignancies in Patients with a Neuroendocrine Neoplasm in England.
    Russell B; White BE; Rous B; Wong K; Bouvier Ellis C; Srirajaskanthan R; Van Hemelrijck M; Ramage JK
    Neuroendocrinology; 2023; 113(8):811-821. PubMed ID: 36940675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Descriptive characteristics of prostate cancer in patients with a history of primary male breast cancer - a SEER analysis.
    Abhyankar N; Hoskins KF; Abern MR; Calip GS
    BMC Cancer; 2017 Sep; 17(1):659. PubMed ID: 28946846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of second cancers among lung cancer patients.
    Salminen E; Pukkala E; Teppo L; Pyrhönen S
    Acta Oncol; 1995; 34(2):165-9. PubMed ID: 7718253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Male Breast Cancer as a Second Primary Cancer: Increased Risk Following Lymphoma.
    Farr DE; Thomas A; Khan SA; Schroeder MC
    Oncologist; 2017 Aug; 22(8):895-900. PubMed ID: 28487463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of invasive cancers following squamous cell skin cancer.
    Levi F; Randimbison L; La Vecchia C; Erler G; Te VC
    Am J Epidemiol; 1997 Nov; 146(9):734-9. PubMed ID: 9366621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.